SCHEMBL19986529

SCHEMBL19986529

CCCCCCCCCc1ccc(Nc2cccc(O)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.56
ESR1 P03372 2/20 0.56
ADRA2A P08913 2/20 0.56
ADORA3 P0DMS8 2/20 0.56
TACR2 P21452 2/20 0.56
SLC6A2 P23975 2/20 0.56
SLC6A4 P31645 2/20 0.56
SLC6A3 Q01959 2/20 0.56
CYP3A4 P08684 2/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
SHBG P04278 1/20 0.56
TP53 P04637 1/20 0.56
HSPD1 P10809 1/20 0.56
ADRB3 P13945 1/20 0.56
HTR2C P28335 1/20 0.56
HSPE1 P61604 1/20 0.56
HIF1A Q16665 1/20 0.56
TST Q16762 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6329259 0.94 CYP3A4 (0.56) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL1423027 0.89 UNG (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL11477061 0.84 ESR1 (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL7651565 0.84 NPSR1 (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL449939 0.82 HTR2A (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL9274463 0.82 HPGD (0.50) ALDH1A1LMNATP53HSD17B10UNG
SCHEMBL27480376 0.82 HTR2A (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL11204938 0.82 HTR2A (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL21634393 0.82 HTR2A (0.54) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL2493792 0.82 HTR2A (0.54) PTGS2ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079985-A1 ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079985-A1 ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS GPX4, GSTO1, LPO PTGS2 568/4885ESR1 1560/4885ADRA2A 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.